MIC-1 serum level and genotype: Associations with progress and prognosis of colorectal carcinoma

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2642-2650

  Brown, David A ^a   Ward, Robyn L ^b   Buckhaults, Philip ^c   Liu, Tao ^a   Romans, Katharine E ^c   Hawkins, Nicholas J ^a   Bauskin, Asne R ^a   Kinzler, Kenneth W ^c   Vogelstein, Bert ^c   Breit, Samuel N ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INHIBITORY CYTOKINE 1; MACROPHAGE MIGRATION INHIBITION FACTOR; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; BLOOD DONOR; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL STRAIN CACO 2; COHORT ANALYSIS; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; UPREGULATION;

ADENOMA; ADENOMATOUS POLYPS; ALLELES; CARCINOMA; CELL LINE, TUMOR; COHORT STUDIES; COLORECTAL NEOPLASMS; CYTOKINES; DISEASE-FREE SURVIVAL; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; LYMPHOCYTES; MALE; NEOPLASM METASTASIS; PROGNOSIS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; UP-REGULATION;

EID: 12444303172     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Blobe, G. C., Schiemann, W. P., and Lodish, H. F. Role of transforming growth factor β in human disease. N. Engl. J. Med., 342: 1350-1358, 2000.
2. Kim, S. J., Im, Y. H., Markowitz, S. D., and Bang, Y. J. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis. Cytokine Growth Factor Rev., 11: 159-168, 2000.
3. Chiao, P. J., Hunt, K. K., Grau, A. M., Abramian, A., Fleming, J., Zhang, W., Breslin, T., Abbruzzese, J. L., and Evans, D. B. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Ann. N. Y. Acad. Sci., 880: 31-37, 1999.
4. Stander, M., Naumann, U., Wick, W., and Weller, M. Transforming growth factor β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res., 296: 221-227, 1999.
5. Huang, Y., and Waxman, S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma cells by phenylbutyrate. Clin. Cancer Res., 4: 2503-2509, 1998.
6. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., and Willson, J. K. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
7. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., and Vogelstein, B. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Wash. DC), 268: 1336-1338, 1995.
8. Ebert, E. C. Inhibitory effects of transforming growth factor β (TGF-β) on certain functions of intraepithelial lymphocytes. Clin. Exp. Immunol., 115: 415-420, 1999.
9. Buckhaults, P., Rago, C., St. Croi, B., Romans, K. E., Saha, S., Zhang, L., Vogelstein, B., and Kinzler, K. W. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res., 61: 6996-7001, 2001.
10. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., Walsh, B. J., Nicholson, R. C., Fairlie, W. D., Por, S. B., Robbins, J. M., and Breit, S. N. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily. Proc. Natl. Acad. Sci. USA, 94: 11514-11519, 1997.
11. Yokoyama-Kobayashi, M., Saeki, M., Sekine, S., and Kato, S. Human cDNA encoding a novel TGF-β superfamily protein highly expressed in placenta. J. Biochem. (Tokyo), 122: 622-626, 1997.
12. Paralkar, V. M., Vail, A. L., Grasser, W. A., Brown, T. A., Xu, H., Vukicevic, S., Ke, H. Z., Qi, H., Owen, T. A., and Thompson, D. D. Cloning and characterization of a novel member of the transforming growth factor β/bone morphogenetic protein family. J. Biol. Chem., 273: 13760-13767, 1998.
13. Strelau, J., Bottner, M., Lingor, P., Suter-Crazzolara, C., Galter, D., Jaszai, J., Sullivan, A., Schober, A., Krieglstein, K., and Unsicker, K. GDF-15/MIC-1 a novel member of the TGF-β superfamily. J. Neural Transm. Suppl., 60: 273-276, 2000.
14. Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y., and Lu, L. PLAB, a novel placental bone morphogenetic protein. Biochim. Biophys. Acta, 1354: 40-44, 1997.
15. Baek, S. J., Horowitz, J. M., and Eling, T. E. Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. J. Biol. Chem., 276: 33384-33392, 2001.
16. Detmer, K., Steele, T. A., Shoop, M. A., and Dannawi, H. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol. Dis., 25: 310-323, 1999.
17. Strelau, J., Sullivan, A., Bottner, M., Lingor, P., Falkenstein, E., Suter-Crazzolara, C., Galter, D., Jaszai, J., Krieglstein, K., and Unsicker, K. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J. Neurosci., 20: 8597-8603, 2000.
18. Krieglstein, K., Strelau, J., Schober, A., Sullivan, A., and Unsicker, K. TGF-β and the regulation of neuron survival and death. J. Physiol. (Paris), 96: 25-30, 2002.
19. Moore, A. G., Brown, D. A., Fairlie, W. D., Bauskin, A. R., Brown, P. K., Munier, M. L., Russell, P. K., Salamonsen, L. A., Wallace, E. M., and Breit, S. N. The transforming growth factor β superfamily cytokine macrophage inhibitory cytokine-1 is present in high concentrations in the serum of pregnant women. J. Clin. Endocrinol. Metab., 85: 4781-4788, 2000.
20. Brown, D. A., Bauskin, A. R., Fairlie, W. D., Smith, M. D., Liu, T., Xu, N., and Breit, S. N. Antibody-based approach to high-volume genotyping for MIC-1 polymorphism. Biotechniques, 33: 118-120, 122, 124 passim, 2002.
21. Brown, D. A., Liu, T., Ward, R. L., Hawkins, N. J., Fairlie, W. D., Bauskin, A. R., Russell, P. J., Quinn, D. I., Grygiel, J. J., Dalley, D., Moore, A. G., Sutherland, R. L., Turner, J., Kingsley, E. A., and Breit, S. N. Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia. J. Leukoc. Biol., (Suppl.) 69: 90, 2001.
22. Fairlie, W. D., Russell, P. K., Wu, W. M., Moore, A. G., Zhang, H. P., Brown, P. K., Bauskin, A. R., and Breit, S. N. Epitope mapping of the transforming growth factor β superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities Biochemistry, 40: 65-73, 2001.
23. Li, P. X., Wong, J., Ayed, A., Ngo, D., Brade, A. M., Arrowsmith, C., Austin, R. C., and Klamut, H. J. Placental transforming growth factor β is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J. Biol. Chem., 275: 20127-20135, 2000.
24. Kannan, K., Amariglio, N., Rechavi, G., and Givol, D. Profile of gene expression regulated by induced p53: connection to the TGF-β family. FEBS Lett., 470: 77-82, 2000.
25. Tan, M., Wang, Y., Guan, K., and Sun, Y. P. TGF-β, a type β transforming growth factor (TGF-β) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-β signaling pathway. Proc. Natl. Acad. Sci. USA, 97: 109-114, 2000.
26. Reddy, B. S., and Rao, C. V. Colon cancer: a role for cyclooxygenase-2-specific nonsteroidal anti-inflammatory drugs. Drugs Aging, 16: 329-334, 2000.
27. Baek, S. J., Kim, K. S., Nixon, J. B., Wilson, L. C., and Eling, T. E. Cyclooxygenase inhibitors regulate the expression of a TGF-β super-family member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol., 59: 901-908, 2001.
28. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61: 5974-5978, 2001.
29. Jass, J. R., Ajioka, Y., Radojkovic, M., Allison, L. J., and Lane, M. R. Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis colorectal cancer. Histopathology, 30: 201-207, 1997.
30. Holand, J. F., et al. (Eds.) Cancer Medicine, Vol. 1, Ed. 3, Philadelphia: Lea and Febiger, 1993.
31. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodriguez-Bigas, M. A., Fodde, R., Ranzani, G. N., and Srivastava, S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res., 58: 5248-5257, 1998.
32. Guidoboni, M., Gafa, R., Viel, A., Doglioni, C., Russo, A., Santini, A., Del Tin, L., Macri, E., Lanza, G., Boiocchi, M., and Dolcetti, R. Microsatellite instability and high content of activated cytotoxic lym-phocytes identify colon cancer patients with a favorable prognosis. Am. J. Pathol., 159: 297-304, 2001.
33. Lucas, P. J., Kim, S. J., Melby, S. J., and Gress, R. E. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J. Exp. Med., 191: 1187-1196, 2000.
34. Engle, S. J., Hoying, J. B., Boivin, G. P., Ormsby, I., Gartside, P. S., and Doetschman, T. Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res., 59: 3379-3386, 1999.